tibalosin

structure given in first source

Also Known As:

1,2,3-dihydro-5-benzo(b)thienyl-2-(4-phenylbutylamino)-1-propanol; CP 804-S; CP-804S; tibalosine; Benzo(b)thiophene-5-methanol, 2,3-dihydro-alpha-(1-((4-phenylbutyl)amino)ethyl)-, hydrochloride

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Amino Alcohols: 20
    - Propanolamines: 4
      - tibalosin: 2
- Alcohols: 595
  - Amino Alcohols: 20
    - Propanolamines: 4
      - tibalosin: 2
  - Propanols: 3
    - Propanolamines: 4
      - tibalosin: 2

Related Diseases

1.	Essential Hypertension 01/01/1986 - "After a run-in period on placebo, 26 patients with essential hypertension were prescribed single-blind tibalosine, 150 mg daily. " 01/01/1986 - "Chronic treatment with tibalosine in essential hypertension." 05/01/1983 - "In a double-blind cross-over study, 12 patients with essential hypertension, on a constant sodium intake, received placebo and tibalosine, 150 mg daily. " 05/01/1983 - "Effects of tibalosine, a new alpha-adrenoceptor antagonist, in essential hypertension."
2.	Body Weight (Weight, Body) 05/01/1983 - "During tibalosine treatment, creatinine clearance decreased by 20 ml/min and serum creatinine rose by 0.04 mg/100 ml. The increase in serum sodium by 0.05 mmol/l was not accompanied by significant changes in body weight. "
3.	Sleepiness 01/01/1986 - "Somnolence, weary legs and dry mouth were reported more frequently (p less than 0.05) on tibalosine than on placebo. "

Related Drugs and Biologics

1.	Sodium
2.	Adrenergic Receptors (Adrenergic Receptor)
3.	Creatinine